Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Intervalo de año de publicación
1.
Andes Pediatr ; 92(1): 93-98, 2021 Feb.
Artículo en Inglés, Español | MEDLINE | ID: mdl-34106188

RESUMEN

INTRODUCTION: Fusobacterium nucleatum is an anaerobic bacillus that is part of the oral microbiota and dental pla que. This can cause local and potentially remote infections, which are exceptional in pediatrics. Ob jective: To present the case of a patient with lung injury with chest wall invasion by Fusobacterium nucleatum. CLINICAL CASE: An 11-year-old female immunocompetent patient who consulted due to a two-week history of cough, night sweats, without fever or weight loss, and increased volume at the left spleen thoracic level. There was no history of chest wall trauma or travel outside the country. Two weeks before the onset of symptoms, she was treated for dental caries. Imaging studies and CT scan showed left spleen pneumonia, which invades the pleura and the chest wall. A minimal thoracotomy was performed, releasing a thick, foul-smelling liquid. The studies for common germs and tubercu losis were negative. Hematology ruled out tumor lesions. The anaerobic study reported the develo pment of Fusobacterium nucleatum. The patient was treated with penicillin followed by amoxicillin presenting good clinical and radiological responses. The dental procedure was suspected as the cause of infection. CONCLUSIONS: Fusobacterium nucleatum can occasionally cause remote or extra-oral in fections in immunocompetent patients, such as pneumonia with chest wall invasion, therefore it is necessary to bear it in mind.


Asunto(s)
Infecciones por Fusobacterium , Fusobacterium nucleatum/aislamiento & purificación , Neumonía Bacteriana/microbiología , Amoxicilina/uso terapéutico , Antibacterianos/uso terapéutico , Niño , Caries Dental/complicaciones , Caries Dental/terapia , Femenino , Infecciones por Fusobacterium/diagnóstico por imagen , Infecciones por Fusobacterium/tratamiento farmacológico , Infecciones por Fusobacterium/cirugía , Humanos , Penicilinas/uso terapéutico , Neumonía Bacteriana/diagnóstico por imagen , Neumonía Bacteriana/tratamiento farmacológico , Neumonía Bacteriana/cirugía , Pared Torácica/microbiología , Toracotomía
2.
Rev Med Chil ; 133(4): 419-25, 2005 Apr.
Artículo en Español | MEDLINE | ID: mdl-15953948

RESUMEN

BACKGROUND: Telithromycin is a new ketolide antimicrobial, that can be useful for the treatment of respiratory infections. AIM: To compare in vitro activity of telithromycin against respiratory pathogens, isolated in outpatient clinics. MATERIAL AND METHODS: Two hundred eighty strains isolated from patients with respiratory infections, were studied. The strains studied were S pneumoniae, penicillin sensitive (SPNS:57); intermediate (SPNI:35), resistant (SPNR:25); S pyogenes (SP:57); H influenzae (HIN 51); M catarrhalis (MC:25) and S aureus meticillin sensitive (SAUS:30). Minimal inhibitory concentration (MIC) by broth microdilution was studied for telitrhomycin and levofloxacin in all strains. Other antimicrobials studied, but not in all strains were erythromycin, clindamycin, trimetoprim sulphamethoxazole, oxacillin, amoxicillin-clavulanic acid and cefuroxime. RESULTS: All strains were sensible to telithromycin at a concentration -4 microg/ml. MIC 90 and its range for SPNS was 0.03 microg/ml (-0.004-0.12), for SPNI was 0.03 microg/ml (-0.004-025), for SPNR was 0.06 microg/ml (-0.004-0.25), for HIN was 2 microg/ml (0.12-4), for SP was 0.5 microg/ml (-0.004-2), for MC was 0.5 microg/ml (0.06-2) and for SAU was 0.25 microg/ml (0.06-0.25). CONCLUSIONS: All studied pathogens were sensible to telithromycin in vitro. This antimicrobial is an alternative for the treatment of community acquired respiratory infections.


Asunto(s)
Antibacterianos/farmacología , Cetólidos/farmacología , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Infecciones Estreptocócicas/tratamiento farmacológico , Infecciones Comunitarias Adquiridas/tratamiento farmacológico , Farmacorresistencia Bacteriana , Haemophilus influenzae/efectos de los fármacos , Humanos , Técnicas In Vitro , Pruebas de Sensibilidad Microbiana , Moraxella catarrhalis/efectos de los fármacos , Staphylococcus aureus/efectos de los fármacos , Streptococcus pneumoniae/efectos de los fármacos , Streptococcus pyogenes/efectos de los fármacos
3.
Rev. méd. Chile ; 133(4): 419-425, abr. 2005. ilus
Artículo en Español | LILACS | ID: lil-417379

RESUMEN

Background: Telithromycin is a new ketolide antimicrobial, that can be useful for the treatment of respiratory infections. Aim: To compare in vitro activity of telithromycin against respiratory pathogens, isolated in outpatient clinics. Material and methods: Two hundred eighty strains isolated from patients with respiratory infections, were studied. The strains studied were S pneumoniae, penicillin sensitive (SPNS:57); intermediate (SPNI:35), resistant (SPNR:25); S pyogenes (SP:57); H influenzae (HIN 51); M catarrhalis (MC:25) and S aureus meticillin sensitive (SAUS:30). Minimal inhibitory concentration (MIC) by broth microdilution was studied for telitrhomycin and levofloxacin in all strains. Other antimicrobials studied, but not in all strains were erythromycin, clindamycin, trimetoprim sulphamethoxazole, oxacillin, amoxicillin-clavulanic acid and cefuroxime. Results: All strains were sensible to telithromycin at a concentration ¡4 µg/ml. MIC 90 and its range for SPNS was 0.03 µg/ml (¡0.004-0.12), for SPNI was 0.03 µg/ml (¡0.004-025), for SPNR was 0.06 µg/ml (¡0.004-0.25), for HIN was 2 µg/ml (0.12-4), for SP was 0.5 µg/ml (¡0.004-2), for MC was 0.5 µg/ml (0.06-2) and for SAU was 0.25 µg/ml (0.06-0.25). Conclusions: All studied pathogens were sensible to telithromycin in vitro. This antimicrobial is an alternative for the treatment of community acquired respiratory infections.


Asunto(s)
Humanos , Antibacterianos/farmacología , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Infecciones Comunitarias Adquiridas/tratamiento farmacológico , Streptococcus pneumoniae , Streptococcus pyogenes
4.
Rev. méd. Chile ; 118(8): 841-5, ago. 1990. tab
Artículo en Español | LILACS | ID: lil-96551

RESUMEN

A toxonomic study of 82 strains of Staphylococci and 6 reference samples isolated from clinical cases was carried out. Results of 47 phenotype tests were submitted to a numerical analysis using the similarity coefficient of Sokal and Michener and a grouping technique (UPGMA). Based on a 75 similarity level, 4 phenons were identified. 37 strains identified as S aureus were grouped in phenon A; 32 strains of S hominis in phenon B; 5 strains of S epidermidis in phenon C and 8 strains of S ssp in phenon D


Asunto(s)
Staphylococcus/clasificación , Técnicas In Vitro , Manejo de Especímenes , Staphylococcus/aislamiento & purificación , Infección Hospitalaria , Técnicas Bacteriológicas
5.
Rev. chil. pediatr ; 60(3): 173-8, mayo-jun. 1989. ilus
Artículo en Español | LILACS | ID: lil-67813

RESUMEN

Se presenta una niña de 14 años con actinomicosis torácica. Se destaca la rara incidencia de esta enfermedad en la edad pediátrica y las dificultades para hacer el diagnóstico. La presencia de una lesión pulmonar de larga evolución, junto a lesiones osteomielíticas de varias costillas y posterior fistulización a la pared costal, con eliminación de los característicos "gránulos de azufre" fueron los elementos claves para sospechar la causa de la enfermedad. Se confirmó el diagnóstico por estudio bacteriológico e histológico. La paciente se trató con dosis altas de penicilina, evolucionando en forma favorable


Asunto(s)
Adolescente , Humanos , Femenino , Actinomicosis/patología , Actinomicosis/diagnóstico , Actinomicosis/tratamiento farmacológico , Fístula , Penicilinas/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...